VIABAHN FORTEGRA Stent for Venous Conditions
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is a prospective, multicenter, single-arm post-market clinical study to evaluate the GORE® VIABAHN® FORTEGRA Venous Stent in real-world use.
Who Is on the Research Team?
Erin Murphy, MD
Principal Investigator
Atrium Health Sanger Heart and Vascular Institute
Parag Patel, MD
Principal Investigator
Medical College of Wisconsin
Are You a Good Fit for This Trial?
This trial is for adults (18+) who have a vein problem, like a blockage or narrowing, that needs treatment with the GORE® VIABAHN® FORTEGRA Venous Stent. Participants must be able to follow study instructions and take any needed medicines or use compression as directed.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- GORE® VIABAHN® FORTEGRA Venous Stent
Trial Overview
The study is testing how safe and effective the GORE® VIABAHN® FORTEGRA Venous Stent is when used in real-world patients with various vein conditions. All participants receive this stent; there is no comparison group.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
GORE® VIABAHN® FORTEGRA Venous Stent
Find a Clinic Near You
Who Is Running the Clinical Trial?
W.L.Gore & Associates
Lead Sponsor
Bret Snyder
W.L.Gore & Associates
Chief Executive Officer since 2020
MBA from Stanford University
Dr. John Doe
W.L.Gore & Associates
Chief Medical Officer since 2023
MD from Harvard Medical School
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.